Profound Medical Corp. said it plans to release its second-quarter 2026 financial results on August 6, with a conference call scheduled to follow. The announcement signals the company’s next update to investors as it reports on recent financial performance and business activity.
The Toronto-based company is listed on both Nasdaq under the ticker PROF and the Toronto Stock Exchange under PRN. Profound Medical describes itself as a commercial-stage medical device business focused on developing and marketing interventional MRI, or iMRI, procedures.
The upcoming earnings release is expected to provide a closer look at the company’s second-quarter results and broader operating progress. A follow-up conference call typically gives management an opportunity to discuss the quarter and address investor questions.
For market participants tracking medical device stocks and imaging-guided treatment technologies, the August 6 update will mark the company’s latest scheduled financial report. The notice keeps attention on Profound Medical as it continues to build its presence in the interventional MRI space.
